Citadel Advisors’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$77K Buy
+17,100
New +$89.1K ﹤0.01% 12199
2025
Q4
Sell
-18,800
Closed -$136K 13743
2025
Q3
$136K Buy
18,800
+4,600
+32% +$27.3K ﹤0.01% 11613
2025
Q2
$75.4K Sell
14,200
-4,000
-22% -$23.6K ﹤0.01% 11533
2025
Q1
$161K Sell
18,200
-2,500
-12% -$30K ﹤0.01% 10753
2024
Q4
$284K Buy
20,700
+2,600
+14% +$48K ﹤0.01% 9765
2024
Q3
$496K Buy
18,100
+3,300
+22% +$89.3K ﹤0.01% 8272
2024
Q2
$362K Buy
14,800
+500
+3% +$11K ﹤0.01% 8732
2024
Q1
$305K Sell
14,300
-9,400
-40% -$202K ﹤0.01% 9421
2023
Q4
$454K Buy
23,700
+10,700
+82% +$185K ﹤0.01% 8320
2023
Q3
$209K Buy
13,000
+4,000
+44% +$76.1K ﹤0.01% 9822
2023
Q2
$209K Buy
9,000
+6,000
+200% +$131K ﹤0.01% 9793
2023
Q1
$69.7K Buy
3,000
+200
+7% +$4.06K ﹤0.01% 11741
2022
Q4
$40.6K Buy
+2,800
New +$52.2K ﹤0.01% 12395
2022
Q3
Sell
-23,300
Closed -$423K 13400
2022
Q2
$423K Sell
23,300
-7,900
-25% -$164K ﹤0.01% 9035
2022
Q1
$786K Sell
31,200
-35,400
-53% -$906K ﹤0.01% 8257
2021
Q4
$1.84M Sell
66,600
-29,300
-31% -$849K ﹤0.01% 6446
2021
Q3
$3.1M Buy
95,900
+65,000
+210% +$2.16M ﹤0.01% 5277
2021
Q2
$945K Sell
30,900
-10,100
-25% -$292K ﹤0.01% 8509
2021
Q1
$1.25M Buy
41,000
+900
+2% +$25.5K ﹤0.01% 7554
2020
Q4
$793K Buy
40,100
+400
+1% +$6.46K ﹤0.01% 7276
2020
Q3
$518K Sell
39,700
-4,000
-9% -$50.6K ﹤0.01% 7246
2020
Q2
$496K Sell
43,700
-13,900
-24% -$197K ﹤0.01% 7090
2020
Q1
$824K Sell
57,600
-10,200
-15% -$215K ﹤0.01% 5669
2019
Q4
$1.85M Sell
67,800
-13,200
-16% -$363K ﹤0.01% 4534
2019
Q3
$2.32M Sell
81,000
-167,500
-67% -$4.88M ﹤0.01% 4246
2019
Q2
$6.9M Buy
248,500
+217,400
+699% +$6.14M 0.01% 2645
2019
Q1
$1.03M Buy
31,100
+12,100
+64% +$368K ﹤0.01% 5528
2018
Q4
$552K Sell
19,000
-15,600
-45% -$561K ﹤0.01% 6248
2018
Q3
$1.59M Buy
34,600
+14,000
+68% +$623K ﹤0.01% 4770
2018
Q2
$770K Sell
20,600
-18,700
-48% -$632K ﹤0.01% 5658
2018
Q1
$1.16M Buy
39,300
+7,700
+24% +$261K ﹤0.01% 4585
2017
Q4
$1.08M Sell
31,600
-3,800
-11% -$128K ﹤0.01% 4547
2017
Q3
$1.28M Sell
35,400
-15,800
-31% -$451K ﹤0.01% 3968
2017
Q2
$1.32M Buy
51,200
+7,300
+17% +$155K ﹤0.01% 3704
2017
Q1
$843K Sell
43,900
-5,900
-12% -$105K ﹤0.01% 4248
2016
Q4
$830K Buy
49,800
+600
+1% +$10.9K ﹤0.01% 4120
2016
Q3
$1.01M Buy
49,200
+31,000
+170% +$786K ﹤0.01% 3822
2016
Q2
$557K Buy
+18,200
New +$632K ﹤0.01% 4337
2016
Q1
Sell
-19,200
Closed -$829K 7600
2015
Q4
$829K Sell
19,200
-8,000
-29% -$338K ﹤0.01% 3813
2015
Q3
$1.02M Buy
27,200
+6,800
+33% +$241K ﹤0.01% 3795
2015
Q2
$693K Sell
20,400
-22,300
-52% -$758K ﹤0.01% 4480
2015
Q1
$1.51M Sell
42,700
-800
-2% -$28.6K ﹤0.01% 3423
2014
Q4
$1.48M Buy
43,500
+10,800
+33% +$383K ﹤0.01% 3269
2014
Q3
$1.26M Sell
32,700
-39,700
-55% -$1.48M ﹤0.01% 3424
2014
Q2
$2.82M Sell
72,400
-18,000
-20% -$670K 0.01% 2398
2014
Q1
$3.09M Sell
90,400
-2,700
-3% -$83.7K 0.01% 2199
2013
Q4
$1.95M Buy
93,100
+80,300
+627% +$2.03M ﹤0.01% 2577
2013
Q3
$301K Sell
12,800
-63,100
-83% -$1.79M ﹤0.01% 4351
2013
Q2
$2.04M Buy
+75,900
New +$2.2M 0.01% 2476

Other funds holding MYGN